The cost burden of Crohn’s disease and ulcerative colitis depending on biologic treatment status – a Danish register-based study

BACKGROUND: Patients diagnosed with inflammatory bowel disease may be treated with biologics, depending on several medical and non-medical factors. This study investigated healthcare costs and production values of patients treated with biologics. METHODS: This national register study included patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Alulis, Sarah, Vadstrup, Kasper, Olsen, Jens, Jørgensen, Tine Rikke, Qvist, Niels, Munkholm, Pia, Borsi, Andras
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371832/
https://www.ncbi.nlm.nih.gov/pubmed/34407821
http://dx.doi.org/10.1186/s12913-021-06816-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371832/
https://www.ncbi.nlm.nih.gov/pubmed/34407821
http://dx.doi.org/10.1186/s12913-021-06816-3

Ejemplares similares